{"key":"op_494_ES","page":{"url":"https://ua.bookimed.com/clinics/country=spain/procedure=medicational-treatment-for-multiple-sclerosis/","procedure":{"id":494,"slug":"medicational-treatment-for-multiple-sclerosis","name":"Медикаментозне лікування розсіяного склерозу","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"neurology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":34,"iso":"ES","name":"Іспанія"},"currency":"USD","data_date":"2026-11-04"},"pages":{"clinics_url":"https://ua.bookimed.com/clinics/country=spain/procedure=medicational-treatment-for-multiple-sclerosis/","cost_url":"https://ua.bookimed.com/clinics/country=spain/procedure=medicational-treatment-for-multiple-sclerosis/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":2500,"to":10000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":11000,"to":28000},"uk":{"from":14000,"to":28000},"by_technique":{"status":"missing","reason":"not_collected"},"by_city":[{"city":"Аліканте","from":3600},{"city":"Барселона","from":4200},{"city":"Мадрид","from":1800}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":4800,"to":9800},{"country_iso":"FR","from":9000,"to":20000},{"country_iso":"GB","from":14000,"to":28000},{"country_iso":"US","from":11000,"to":28000},{"country_iso":"IL","from":9000,"to":19000},{"country_iso":"TR","from":2500,"to":15500},{"country_iso":"MX","from":7000,"to":16000},{"country_iso":"DE","from":3300,"to":14000},{"country_iso":"CA","from":18000,"to":40000},{"country_iso":"AE","from":9000,"to":21000},{"country_iso":"TH","from":3000,"to":6000},{"country_iso":"PL","from":6500,"to":13000},{"country_iso":"KR","from":2200,"to":6000},{"country_iso":"CZ","from":9000,"to":19000},{"country_iso":"AT","from":10500,"to":19000},{"country_iso":"IT","from":7000,"to":12500},{"country_iso":"CN","from":4500,"to":11000},{"country_iso":"AU","from":14000,"to":29000},{"country_iso":"IN","from":3500,"to":6500},{"country_iso":"MY","from":6000,"to":16000},{"country_iso":"VN","from":3500,"to":8000},{"country_iso":"BR","from":6000,"to":9000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":77,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":5,"items":[{"id":78,"name":"Centro Médico Teknon","city":"Barcelona","rating":4.7,"reviews_count":497,"accreditations":["Joint Commission International","European Foundation for Quality Management","THE IMTJ MEDICAL TRAVEL AWARD WINNER IN 2019","Patient choice in Neurology","Patient choice in Neurosurgery","Patient choice for Epilepsy treatment","World's Best Hospitals 2021 by Newsweek"],"rank":1,"has_procedure":true,"why_ranked":"Specializes in neuroimmunology with advanced infusion therapy using Rituximab or Ocrevus. JCI-accredited with a 4.7 clinic rating based on 409 patient reviews.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":6225,"name":"Hospital Ruber Internacional","city":"Madrid","rating":5,"reviews_count":3,"accreditations":["Joint Commission International","International Organization for Standardization"],"rank":2,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":278,"name":"Quironsalud Madrid","city":"Madrid","rating":3.8,"reviews_count":6,"accreditations":["World's Best Hospitals 2021 by Newsweek"],"rank":3,"has_procedure":true,"why_ranked":"Head neurologist has led 100 clinical trials in MS research. Clinic offers personalized treatment plans with the latest MS medications, including immunotherapy options.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":310,"name":"HOSPITAL UNIVERSITARIO HM MADRID","city":"Madrid","rating":4.7,"reviews_count":17,"accreditations":["European Foundation for Quality Management","TÜV AG Сompany Research & Investing Certificate","World's Best Hospitals 2021 by Newsweek"],"rank":4,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":422,"name":"Hospital HM Nou Delfos","city":"Barcelona","rating":4.6,"reviews_count":5,"accreditations":["European Foundation for Quality Management","Certification according to DIN EN ISO 9001 by TÜV NORD CERT"],"rank":5,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":3,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":441,"slug":"alicante","name":"Аліканте","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":3600,"profile":{"city_type":"Mediterranean port city in Spain","access":["Alicante Airport (ALC), 9 km from the city"],"sources":["https://en.wikipedia.org/wiki/Alicante","https://en.wikipedia.org/wiki/Alicante%E2%80%93Elche_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":98,"slug":"barcelona","name":"Барселона","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":4200,"profile":{"city_type":"Mediterranean coastal city in Spain","access":["Barcelona Airport (BCN), 15 km southwest of city center"],"sources":["https://en.wikipedia.org/wiki/Barcelona","https://en.wikipedia.org/wiki/Barcelona–El_Prat_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":346,"slug":"madrid","name":"Мадрид","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":1800,"profile":{"city_type":"Capital and largest city of Spain","access":["Madrid Barajas Airport (MAD), 13 km from Puerta del Sol"],"sources":["https://en.wikipedia.org/wiki/Madrid","https://en.wikipedia.org/wiki/Madrid–Barajas_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Relapsing-remitting multiple sclerosis","Active secondary progressive multiple sclerosis","Clinically isolated syndrome with high-risk MRI lesions","Primary progressive multiple sclerosis (selected agents, such as ocrelizumab)"],"contraindications":["Active serious infection","Pregnancy or breastfeeding (agent-specific)","Known hypersensitivity to the agent","Severe immunosuppression or active malignancy","Severe liver impairment","High PML risk (JC virus positive) for natalizumab","Untreated hepatitis B, HIV or tuberculosis","Significant cardiac conduction disease (S1P modulators)"],"operation_hours":{"min":1,"max":6,"unit":"hours","qualifier":"Injection takes minutes; infusion visits run 1-6 hours depending on agent."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":2,"max":4,"unit":"visits","qualifier":"Travel visits for initial dosing and periodic infusions; oral or injectable agents are self-administered between visits."},"stages":[{"code":"workup","label":"Workup and MRI","after":{"min":0,"max":3,"unit":"days","qualifier":"Initial assessment and screening tests."}},{"code":"first_dose","label":"First dose or infusion","after":{"min":3,"max":7,"unit":"days","qualifier":"Begins after screening results."}},{"code":"monitoring","label":"Monitoring visit with MRI","after":{"min":180,"max":365,"unit":"days","qualifier":"Repeat review every 6-12 months."}}],"qualifier":"Long-term therapy with ongoing dosing; schedule depends on the chosen agent."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Treatment is given as outpatient infusion, injection or oral dosing without overnight stay."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"status":"missing","reason":"not_collected"},"fly_home_after_days":{"min":1,"max":3,"unit":"days","qualifier":"After first infusion or first-dose monitoring and neurologist clearance; depends on agent."},"back_to_work_days":{"min":0,"max":2,"unit":"days","qualifier":"Oral or injectable agents need no time off; infusion days may need one day of rest."},"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Usual activity can resume within days; fatigue and heat sensitivity may limit intensity."},"final_result_months":{"min":6,"max":12,"unit":"months","qualifier":"Full effect on relapses and MRI activity builds over months; varies by agent."},"result_longevity":"Effect lasts only while therapy continues, except short-course agents with prolonged action. Treatment is usually long-term and reviewed regularly.","main_risks":["Serious infections, including PML with some agents","Infusion or injection-site reactions","Liver enzyme elevation","Low blood cell counts","Secondary autoimmune disease with some agents","Rebound disease activity after stopping some agents"],"complication_rate_pct":{"min":10,"max":40,"unit":"percent","qualifier":"Any treatment-related adverse event needing attention, agent-dependent; serious events usually under 5%."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Relapse-free patients on disease-modifying therapy","value":65,"horizon":"2 years","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"None; no incisions, only minor injection or cannula sites.","pain":"Little pain; mild injection-site discomfort or cannula insertion. Flu-like symptoms or headache may occur with some agents.","preparation":["Brain and spinal MRI","Blood tests including liver and blood count","JC virus antibody test","Hepatitis, tuberculosis and varicella screening","Review of previous MS therapies","Pregnancy test and contraception planning","Vaccination review before starting"],"recovery_timeline":[{"phase":"Treatment day","description":"First dose or infusion given with monitoring for reactions.","restrictions":["Avoid driving if drowsy after premedication"]},{"phase":"First weeks","description":"Possible flu-like symptoms or injection reactions; early blood tests check safety.","restrictions":["Report infections or new symptoms promptly"]},{"phase":"Ongoing therapy","description":"Regular dosing with periodic MRI and blood monitoring over months to years.","restrictions":["Contraception planning where required","Avoid live vaccines on most agents"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":60,"unit":"days","qualifier":"Early safety review with blood tests, depending on agent."}},{"purpose":"result_review","requirement":"routine","after":{"min":180,"max":365,"unit":"days","qualifier":"Neurological exam and MRI to assess disease activity."}},{"purpose":"other","requirement":"conditional","after":{"min":30,"max":365,"unit":"days","qualifier":"For relapse, side effects or abnormal monitoring results."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the proposed treatment suits your MS type and symptoms, since treatment depends on both","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/multiple-sclerosis/treatment/","host":"nhs.uk","quote":"The type of treatment will depend on the type of MS you have and your symptoms.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check the plan allows for treatment changes, since you'll probably need different treatments over time","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/multiple-sclerosis/treatment/","host":"nhs.uk","quote":"You'll probably need different treatments over time.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Check the doctor will monitor your symptoms and test results over time, as diagnosing the MS type can take time","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/multiple-sclerosis/treatment/","host":"nhs.uk","quote":"Your neurologist may need to monitor your symptoms and test results for some time to diagnose which type you have.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Check who will support you, which may include a specialist MS nurse and a neurologist","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/multiple-sclerosis/treatment/","host":"nhs.uk","quote":"This may include a specialist MS nurse, a neurologist (brain and nerve specialist), physiotherapist and occupational therapist.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Check the plan addresses your own symptoms, since every person's needs will be different","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/multiple-sclerosis/treatment/","host":"nhs.uk","quote":"Every person's needs will be different depending on their symptoms.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F2","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"A price that sounds too good to be true probably is","scope":"treatment_abroad","source":{"url":"https://www.plasticsurgery.org/news/articles/will-economic-uncertainty-drive-more-patients-overseas-for-plastic-surgery-what-to-consider-and-how-to-stretch-your-dollar-back-home","host":"plasticsurgery.org","quote":"If the price sounds too good to be true, it probably is.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Swelling of face, lips, tongue, or throat","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/18442-ocrelizumab-injection","host":"my.clevelandclinic.org","quote":"Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Chest pain or trouble breathing","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/18442-ocrelizumab-injection","host":"my.clevelandclinic.org","quote":"Infusion reactions—chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Confusion or trouble speaking","urgency":"emergency","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/18442-ocrelizumab-injection","host":"my.clevelandclinic.org","quote":"Dizziness, loss of balance or coordination, confusion or trouble speaking","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W4","text":"Fever, chills, or sore throat","urgency":"contact_clinic","general":true,"source":{"url":"https://my.clevelandclinic.org/health/drugs/18442-ocrelizumab-injection","host":"my.clevelandclinic.org","quote":"Call your care team for advice if you get a fever, chills, sore throat, or other symptoms of a cold or flu.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":0,"max":2,"unit":"days","qualifier":"Oral or injectable agents need no time off; infusion days may need one day of rest."},"complication_rate_pct":{"min":10,"max":40,"unit":"percent","qualifier":"Any treatment-related adverse event needing attention, agent-dependent; serious events usually under 5%."},"contraindications":["Active serious infection","Pregnancy or breastfeeding (agent-specific)","Known hypersensitivity to the agent","Severe immunosuppression or active malignancy","Severe liver impairment","High PML risk (JC virus positive) for natalizumab","Untreated hepatitis B, HIV or tuberculosis","Significant cardiac conduction disease (S1P modulators)"],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Treatment is given as outpatient infusion, injection or oral dosing without overnight stay."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Usual activity can resume within days; fatigue and heat sensitivity may limit intensity."},"final_result_months":{"min":6,"max":12,"unit":"months","qualifier":"Full effect on relapses and MRI activity builds over months; varies by agent."},"fly_home_after_days":{"min":1,"max":3,"unit":"days","qualifier":"After first infusion or first-dose monitoring and neurologist clearance; depends on agent."},"follow_up_visits":[{"purpose":"assessment","after":{"min":14,"max":60,"unit":"days","qualifier":"Early safety review with blood tests, depending on agent."},"requirement":"routine"},{"purpose":"result_review","after":{"min":180,"max":365,"unit":"days","qualifier":"Neurological exam and MRI to assess disease activity."},"requirement":"routine"},{"purpose":"other","after":{"min":30,"max":365,"unit":"days","qualifier":"For relapse, side effects or abnormal monitoring results."},"requirement":"conditional"}],"indications":["Relapsing-remitting multiple sclerosis","Active secondary progressive multiple sclerosis","Clinically isolated syndrome with high-risk MRI lesions","Primary progressive multiple sclerosis (selected agents, such as ocrelizumab)"],"main_risks":["Serious infections, including PML with some agents","Infusion or injection-site reactions","Liver enzyme elevation","Low blood cell counts","Secondary autoimmune disease with some agents","Rebound disease activity after stopping some agents"],"pain":"Little pain; mild injection-site discomfort or cannula insertion. Flu-like symptoms or headache may occur with some agents.","preparation":["Brain and spinal MRI","Blood tests including liver and blood count","JC virus antibody test","Hepatitis, tuberculosis and varicella screening","Review of previous MS therapies","Pregnancy test and contraception planning","Vaccination review before starting"],"recovery_timeline":[{"phase":"Treatment day","description":"First dose or infusion given with monitoring for reactions.","restrictions":["Avoid driving if drowsy after premedication"]},{"phase":"First weeks","description":"Possible flu-like symptoms or injection reactions; early blood tests check safety.","restrictions":["Report infections or new symptoms promptly"]},{"phase":"Ongoing therapy","description":"Regular dosing with periodic MRI and blood monitoring over months to years.","restrictions":["Contraception planning where required","Avoid live vaccines on most agents"]}],"rehabilitation_days":null,"result_longevity":"Effect lasts only while therapy continues, except short-course agents with prolonged action. Treatment is usually long-term and reviewed regularly.","revision_rate_pct":null,"scars":"None; no incisions, only minor injection or cannula sites.","sessions_or_stages":{"sessions":{"min":2,"max":4,"unit":"visits","qualifier":"Travel visits for initial dosing and periodic infusions; oral or injectable agents are self-administered between visits."},"stages":[{"code":"workup","label":"Workup and MRI","after":{"min":0,"max":3,"unit":"days","qualifier":"Initial assessment and screening tests."}},{"code":"first_dose","label":"First dose or infusion","after":{"min":3,"max":7,"unit":"days","qualifier":"Begins after screening results."}},{"code":"monitoring","label":"Monitoring visit with MRI","after":{"min":180,"max":365,"unit":"days","qualifier":"Repeat review every 6-12 months."}}],"qualifier":"Long-term therapy with ongoing dosing; schedule depends on the chosen agent."},"success":{"metric":"Relapse-free patients on disease-modifying therapy","value":65,"unit":"percent","horizon":"2 years","population":"Adults with relapsing-remitting MS on disease-modifying therapy; lower with older injectables, higher with high-efficacy agents","evidence_status":"limited"},"techniques":[{"name":"Injectable agents (interferon beta, glatiramer, ofatumumab)","suits_whom":"Mild to moderate relapsing MS; ofatumumab also for active disease","recovery":"Self-injected; no recovery time."},{"name":"Oral agents (S1P modulators, fumarates, teriflunomide, cladribine)","suits_whom":"Relapsing MS preferring tablets","recovery":"No recovery time; blood monitoring needed."},{"name":"Infusion antibodies (natalizumab, ocrelizumab, alemtuzumab)","suits_whom":"Active or highly active relapsing MS","recovery":"Rest after infusion; observation for reactions."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":1,"max":6,"unit":"hours","qualifier":"Injection takes minutes; infusion visits run 1-6 hours depending on agent."},"initial_assessment_documents":["Brain and spinal cord MRI reports","Recent brain and spinal MRI images (DICOM)","Neurologist report with EDSS score","Relapse history with dates","List of previous MS therapies","Blood test results including liver and JC virus"],"travel_trips":{"min":2,"max":4,"one_trip_possible":false,"qualifier":"Long-term therapy: 3-7 days for workup and start, then visits for infusions, MRI, monitoring every 6-12 months."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the proposed treatment suits your MS type and symptoms, since treatment depends on both","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/multiple-sclerosis/treatment/","host":"nhs.uk","quote":"The type of treatment will depend on the type of MS you have and your symptoms.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check the plan allows for treatment changes, since you'll probably need different treatments over time","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/multiple-sclerosis/treatment/","host":"nhs.uk","quote":"You'll probably need different treatments over time.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Check the doctor will monitor your symptoms and test results over time, as diagnosing the MS type can take time","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/multiple-sclerosis/treatment/","host":"nhs.uk","quote":"Your neurologist may need to monitor your symptoms and test results for some time to diagnose which type you have.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Check who will support you, which may include a specialist MS nurse and a neurologist","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/multiple-sclerosis/treatment/","host":"nhs.uk","quote":"This may include a specialist MS nurse, a neurologist (brain and nerve specialist), physiotherapist and occupational therapist.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Check the plan addresses your own symptoms, since every person's needs will be different","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/multiple-sclerosis/treatment/","host":"nhs.uk","quote":"Every person's needs will be different depending on their symptoms.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F2","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"A price that sounds too good to be true probably is","scope":"treatment_abroad","source":{"url":"https://www.plasticsurgery.org/news/articles/will-economic-uncertainty-drive-more-patients-overseas-for-plastic-surgery-what-to-consider-and-how-to-stretch-your-dollar-back-home","host":"plasticsurgery.org","quote":"If the price sounds too good to be true, it probably is.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Swelling of face, lips, tongue, or throat","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/18442-ocrelizumab-injection","host":"my.clevelandclinic.org","quote":"Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Chest pain or trouble breathing","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/18442-ocrelizumab-injection","host":"my.clevelandclinic.org","quote":"Infusion reactions—chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Confusion or trouble speaking","urgency":"emergency","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/18442-ocrelizumab-injection","host":"my.clevelandclinic.org","quote":"Dizziness, loss of balance or coordination, confusion or trouble speaking","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W4","text":"Fever, chills, or sore throat","urgency":"contact_clinic","general":true,"source":{"url":"https://my.clevelandclinic.org/health/drugs/18442-ocrelizumab-injection","host":"my.clevelandclinic.org","quote":"Call your care team for advice if you get a fever, chills, sore throat, or other symptoms of a cold or flu.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"alternatives":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-13","next_check_at":"2027-02-11"},"technique_details":{"status":"ok","items":[{"id":"injectable-agents","name":"Injectable agents (interferon beta, glatiramer, ofatumumab)","how_it_works":{"text":"Medicine is injected under the skin or into a muscle","source":{"url":"https://my.clevelandclinic.org/health/drugs/19771-peginterferon-beta-1a","host":"my.clevelandclinic.org","quote":"This medication is injected under the skin or into a muscle.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"oral-agents","name":"Oral agents (S1P modulators, fumarates, teriflunomide, cladribine)","how_it_works":{"text":"Medicine comes as a tablet that is taken with water","source":{"url":"https://my.clevelandclinic.org/health/drugs/21275-siponimod-tablets","host":"my.clevelandclinic.org","quote":"This medication comes in a tablet form that you can take with water.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"infusion-antibodies","name":"Infusion antibodies (natalizumab, ocrelizumab, alemtuzumab)","how_it_works":{"text":"Infused antibodies slow an overactive immune system to prevent or delay symptoms","source":{"url":"https://my.clevelandclinic.org/health/drugs/18442-ocrelizumab-injection","host":"my.clevelandclinic.org","quote":"It works by slowing down an overactive immune system to prevent or delay symptoms.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1}}},"techniques":[{"id":"injectable-agents","name":"Injectable agents (interferon beta, glatiramer, ofatumumab)","how_it_works":{"id":"H1","text":"Medicine is injected under the skin or into a muscle","source":{"url":"https://my.clevelandclinic.org/health/drugs/19771-peginterferon-beta-1a","host":"my.clevelandclinic.org","quote":"This medication is injected under the skin or into a muscle.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Mild to moderate relapsing MS; ofatumumab also for active disease","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Self-injected; no recovery time."},{"id":"oral-agents","name":"Oral agents (S1P modulators, fumarates, teriflunomide, cladribine)","how_it_works":{"id":"H1","text":"Medicine comes as a tablet that is taken with water","source":{"url":"https://my.clevelandclinic.org/health/drugs/21275-siponimod-tablets","host":"my.clevelandclinic.org","quote":"This medication comes in a tablet form that you can take with water.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Relapsing MS preferring tablets","price_from":{"status":"missing","reason":"not_collected"},"recovery":"No recovery time; blood monitoring needed."},{"id":"infusion-antibodies","name":"Infusion antibodies (natalizumab, ocrelizumab, alemtuzumab)","how_it_works":{"id":"H1","text":"Infused antibodies slow an overactive immune system to prevent or delay symptoms","source":{"url":"https://my.clevelandclinic.org/health/drugs/18442-ocrelizumab-injection","host":"my.clevelandclinic.org","quote":"It works by slowing down an overactive immune system to prevent or delay symptoms.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Active or highly active relapsing MS","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Rest after infusion; observation for reactions."}],"alternatives":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-13","next_check_at":"2027-02-11"},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"passport_validity","audience":"uk","volatile":true,"text":"The passport must have an expiry date at least 3 months after you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"medicines","audience":"all","volatile":false,"text":"Carry prescription medication in its original packaging, along with your doctor's prescription","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Always carry your prescription medication in original packaging, along with your doctor’s prescription.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"prescriptions","audience":"us","volatile":false,"text":"Medications that require a prescription in the United States also require a local doctor's prescription in Spain","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Medications requiring prescriptions in the United States also require a local doctor’s prescription in Spain.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V4","item":"ghic","audience":"uk","volatile":false,"text":"A GHIC or EHIC is needed to get medically necessary state healthcare in Spain","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Spain, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V5","item":"hospital_payment","audience":"all","volatile":false,"text":"Private hospitals usually require payment or proof of insurance or funds before admitting a patient","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Private hospitals usually require payment or proof insurance or funds before admitting a patient.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["austria","azerbaijan","china","germany","india","israel","italy","japan","mexico","republic-of-korea","switzerland","thailand","turkey","ukraine","united-arab-emirates"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.69,"count":528,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Medication treatment for multiple sclerosis in Spain typically costs from _op_494_price_from_ to _op_494_price_to_ depending on the specific drug protocol, clinic tier, and required diagnostic monitoring. In the US, similar treatments cost around _price_compare_US_average_ on average. Patients seeking care in Spain can achieve savings of approximately _price_percent_discount_%. Budget estimates usually cover neurologist consultations, initial blood work, and the primary pharmacological therapy.</p>\n\n<ul>\n<li><strong>Ocrevus (ocrelizumab):</strong> _op_565_price_from_ to _op_565_price_to_ for high-efficacy infusion therapy.</li>\n<li><strong>Diagnostic imaging:</strong> Brain MRI with contrast typically adds $400 to $1,200 to initial costs.</li>\n<li><strong>Specialist consultations:</strong> Private neurology sessions in Madrid or Barcelona range from $300 to $550.</li>\n<li><strong>Neurorehabilitation:</strong> Intensive 30-day programs often cost between $10,000 and $20,000 for comprehensive care.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Spain offers elite neurological care with research-driven value. Quironsalud Madrid provides access to over 100 clinical trials for neurodegenerative disorders. For those seeking advanced diagnostics, Hospital HM Nou Delfos utilizes EOS imaging and MRI technology. Expert neurologists like Dr. Rafael Arroyo González, a published researcher in The Lancet, lead these programs. This allows patients to access world-class expertise at significantly lower private rates than North American alternatives.</p>","faq":[{"q":"How often are infusion treatments for MS scheduled in Spain?","a":"<p>Infusion schedules for multiple sclerosis in Spain typically range from monthly to once every 6 months depending on the specific medication. Standard dosing for Tysabri occurs every 4 weeks, while Ocrevus requires maintenance every 24 weeks at JCI-accredited facilities in Madrid and Barcelona.</p> <ul> <li><strong>Ocrevus maintenance:</strong> Maintenance infusions are performed every 6 months following initial priming doses.</li> <li><strong>Tysabri intervals:</strong> Standard dosing occurs every 28 days with potential extended dosing every 6 weeks.</li> <li><strong>Ublituximab schedule:</strong> Patients receive maintenance doses every 24 weeks after the initial two-week loading phase.</li> <li><strong>Alternative options:</strong> Newer therapies like Kesimpta may allow for dosing intervals of 60 to 90 days.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While standard protocols are rigid, Spanish centers like Hospital Ruber Internacional and Quironsalud Madrid often participate in advanced clinical trials. This high research volume, led by specialists like Dr. Rafael Arroyo González, allows for personalized dosing adjustments. Neurologists may extend intervals to 6 weeks for Tysabri to balance medication efficacy with patient tolerance and lifestyle needs.</p> <p><strong>Patient Consensus:</strong> Many patients notice a predictable increase in fatigue roughly 2 weeks before their next appointment, often called the crap gap. Coordination with a neurologist is essential to manage these symptoms as the scheduled date approaches.</p>"},{"q":"What is the standard of care for MS treatment in Spain?","a":"<p>Spain provides high-quality multiple sclerosis care centered in designated reference units. Treatment follows international European Committee for Treatment and Research in Multiple Sclerosis standards, prioritizing early intervention with disease-modifying therapies. Patients access specialized neurological care through JCI-accredited facilities in major hubs like Madrid and Barcelona.</p> <ul> <li><strong>Therapeutic approach:</strong> Clinics utilize escalation methods or immediate high-efficacy therapy based on prognostic factors.</li> <li><strong>Medication access:</strong> Standard options include dimethyl fumarate and infusions like ocrelizumab or natalizumab.</li> <li><strong>Specialized centers:</strong> Reference centers like Hospital Ruber Internacional utilize 3-Tesla MRI for precise monitoring.</li> <li><strong>Diagnostic monitoring:</strong> Protocols require mandatory MRI scans 3 to 6 months after starting therapies.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While Spain offers world-class care, patients transferring from abroad should bring physical MRI CDs. Spanish neurologists, including those at Quironsalud Madrid, often require fresh imaging before approving high-efficacy drugs. This ensures treatment aligns with local regulatory protocols for top-tier medications.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the need for a 3-month medication supply when relocating to bridge administrative gaps. They often recommend private insurance to bypass public health restrictions on specific high-efficacy treatments.</p>"},{"q":"How are treatment decisions made in Spain?","a":"<p>Treatment decisions in Spain are centered on multidisciplinary teams within specialized Referral Centres (CSUR). While specialists lead the clinical strategy, patients aged 16 and older hold legal capacity for medical consent. Decisions prioritize medication availability and long-term neuroprotection, often utilizing Joint Commission International-accredited facilities for complex neurological care.</p> <ul> <li><strong>Specialized units:</strong> Expert teams at centers like Hospital Ruber Internacional coordinate complex neurological treatment plans.</li> <li><strong>Legal consent:</strong> Patients reach the age of medical majority at 16 in Spain.</li> <li><strong>Regional coordination:</strong> Public and private care models prioritize proximity to the patient's residence.</li> <li><strong>Specialist leadership:</strong> Neurologists like Dr. Rafael Arroyo González direct care through extensive clinical research.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain’s leading neurology departments focus heavily on clinical trial access for neurodegenerative disorders. Centers like Quironsalud Madrid often provide eligible patients access to the newest medications through these trials before they reach the general market. This creates a unique opportunity for patients whose conditions do not respond to standard therapies.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the need to bring organized medical records and MRI scans to avoid diagnostic delays. Many note that treatment choices may be limited by local medication stock despite overall high care quality.</p>"},{"q":"Are high-efficacy disease-modifying therapies (DMTs) available?","a":"<p>High-efficacy disease-modifying therapies (HE-DMTs) like ocrelizumab and ofatumumab are standard treatments in Spain for managing multiple sclerosis. Spanish clinics prioritize early intervention strategies to prevent long-term disability, offering advanced infusions and self-injection options that significantly reduce clinical relapses and central nervous system damage.</p> <ul> <li><strong>Available medications:</strong> Ocrelizumab, ofatumumab, natalizumab, and alemtuzumab are readily accessible at specialized Spanish centers.</li> <li><strong>Treatment frequency:</strong> Options range from monthly self-injections to hospital-based infusions administered every 6 months.</li> <li><strong>Safety protocols:</strong> Neurologists perform essential screenings, such as JC virus antibody testing before starting natalizumab.</li> <li><strong>Clinical expertise:</strong> Leading specialists like Dr. Rafael Arroyo González at Quironsalud Madrid lead national research.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain has become a major hub for neurodegenerative research, with centers like Quironsalud Madrid conducting over 100 clinical trials. This high volume of research often allows patients to access the latest therapy protocols or participate in trials that might not be available in other regions.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the importance of starting high-efficacy drugs immediately to stop silent disease progression. Many report that modern treatments like Kesimpta or Ocrevus have minimal side effects, allowing them to maintain active daily lives.</p>"},{"q":"How can I access MS treatment through the Spanish Public Health System?","a":"<p>Accessing multiple sclerosis treatment through the Spanish Public Health System requires legal residency and social security contributions. Patients must register for a Sip Card to obtain free or heavily subsidized disease-modifying therapies from neurologists in Joint Commission International-accredited facilities across Madrid and Barcelona.</p> <ul> <li><strong>Residency requirement:</strong> Access depends on employment, social security contributions, or specific non-lucrative residency visas.</li> <li><strong>Access pathway:</strong> Patients register with local primary care doctors for neurology referrals and prescriptions.</li> <li><strong>Medication coverage:</strong> Public systems cover advanced therapies like Ocrevus and Kesimpta with minimal patient co-payments.</li> <li><strong>Clinical trials:</strong> Centers like Quironsalud Madrid offer potential free access through neurodegenerative research projects.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While private care in Spain is high-quality, most private insurers explicitly exclude pre-existing conditions like multiple sclerosis. Data shows that drugs like Ocrevus can cost up to _op_565_price_to_ per year privately, so securing a Spanish residency status that grants public health access is the most sustainable path for long-term treatment.</p> <p><strong>Patient Consensus:</strong> Many patients recommend bringing complete medical records and MRI scans from home to speed up the public registration process. Expect a short wait for the initial neurologist referral, so carrying a two-month medication buffer is essential for a smooth transition.</p>"},{"q":"What are the Spanish recommendations for pregnancy and MS?","a":"<p>Spanish recommendations for multiple sclerosis (MS) and pregnancy emphasize proactive clinical stability. The Spanish Society of Neurology (SEN) advises delaying pregnancy for 12 months after a relapse. First-line therapies like interferon-beta and glatiramer acetate are safe for use throughout pregnancy without interruption.</p> <ul> <li><strong>Planning window:</strong> Delay pregnancy for 12 months if clinically or radiologically unstable.</li> <li><strong>Treatment safety:</strong> interferon-beta and glatiramer acetate have no pregnancy contraindications.</li> <li><strong>Postpartum protocol:</strong> Resume disease-modifying therapy immediately if you are not breastfeeding.</li> <li><strong>Monitoring limits:</strong> Avoid routine MRI scans during pregnancy to protect fetal development.</li> <li><strong>Lifestyle habits:</strong> Prioritize vitamin D, folic acid, and immediate smoking cessation.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain ranks third globally for neurological care on Bookimed, largely due to experts like Prof. Dr. Rafael Arroyo González at Quironsalud Madrid. His research on viral factors in MS aligns with the high-precision diagnostic tools at top Madrid clinics. Patients seeking pregnancy planning benefit from centers with 3-Tesla MRI and specialized neuro-maternity protocols.</p> <p><strong>Patient Consensus:</strong> Many patients find that pregnancy naturally reduces MS activity for years. Coordination of infusion timing before conception is essential to ensure continuous protection during the breastfeeding window.</p>"},{"q":"What is the procedure for a foreign resident to get medication?","a":"<p>Foreign residents in Spain must access specialized medications like multiple sclerosis therapies primarily through the public healthcare system (Seguridad Social). To obtain a prescription, you must establish legal residency and pay social security contributions, usually by working as an employee or being self-employed.</p> <ul> <li><strong>Public healthcare access:</strong> Legal residency and social security contributions are required to access public neurologists.</li> <li><strong>Pre-existing conditions:</strong> Private insurance providers in Spain generally exclude coverage for pre-existing chronic conditions.</li> <li><strong>Neurology consultations:</strong> Private appointments for initial evaluations typically cost approximately $250 without insurance coverage.</li> <li><strong>Medication supply:</strong> Experts recommend bringing a 6–12 month supply to bridge healthcare registration gaps.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While Spain ranks third globally for medical requests on our platform, patients often overlook the administrative timeline. Specialists like Dr. Rafael Arroyo González at Quironsalud Madrid participate in over 100 clinical trials, making these centers ideal for verifying complex histories before you enter the public system.</p> <p><strong>Patient Consensus:</strong> Patients emphasize gathering complete medical history, including MRI scans on discs, before relocating. Moving as a self-employed worker is the fastest way to secure state-covered treatment and avoid high costs.</p>"},{"q":"Are there non-medication treatments covered in Spain?","a":"<p>Spain covers various non-medication multiple sclerosis treatments through its public healthcare system for legal residents. Covered services include physical therapy, specialized neurorehabilitation, speech therapy, and occupational therapy. Prescribed mobility aids like wheelchairs and walkers are also available when deemed medically necessary by a neurologist.</p> <ul> <li><strong>Physical therapy:</strong> Focuses on managing spasticity, improving gait, and maintaining muscle mobility.</li> <li><strong>Neurorehabilitation:</strong> Comprehensive programs help patients regain daily function and independence.</li> <li><strong>Speech therapy:</strong> Addresses communication difficulties and swallowing issues common in advanced stages.</li> <li><strong>Occupational therapy:</strong> Provides strategies for managing fatigue and adapting home environments.</li> <li><strong>Mobility aids:</strong> Includes prescribed wheelchairs, walkers, and orthotics through the public system.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While public hospitals provide excellent care, top private centers like Hospital HM Nou Delfos partner with specialized institutions such as Institut Guttmann. This link gives patients access to Joint Commission International-accredited neurorehabilitation that ranks among the best in Europe.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that securing legal residency is the only reliable way to access these therapies. Most report that private insurance companies often exclude pre-existing multiple sclerosis, making the public system the primary path for long-term rehabilitation.</p>"}],"h2":[{"text":"Як це працює","kind":"content"},{"text":"Яка вартість медикаментозного лікування розсіяного склерозу в Іспанії?","kind":"content"},{"text":"Дізнайтеся про найкращі клініки з медикаментозного лікування розсіяного склерозу у Іспанії: 5 перевірених клінік та ціни","kind":"content"},{"text":"Огляд процедури Медикаментозне лікування розсіяного склерозу в Іспанії","kind":"content"},{"text":"Отримайте медичну консультацію щодо медикаментозного лікування розсіяного склерозу в Іспанії: Обирайте серед найкращих фахівців у галузі","kind":"content"},{"text":"Відеоісторії пацієнтів Bookimed","kind":"content"},{"text":"Відгуки про Bookimed: дізнайтеся про реальний досвід пацієнтів","kind":"content"},{"text":"Поділитися цим контентом","kind":"content"},{"text":"FAQ з медикаментозного лікування розсіяного склерозу в Іспанії","kind":"content"},{"text":"Отримати безкоштовну консультацію","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}